Patient characteristics by treatment group
| MPEC (n = 16) | APC (n = 19) | p Value | |
|---|---|---|---|
| BO, Barrett’s oesophagus, PPI, proton pump inhibitor. | |||
| Age (y) | 60 (42–68) | 65 (32–84) | 0.18 |
| BO length (cm) median(range) | 3 (2–6) | 4 (2–6) | 0.52 |
| Hiatal hernia size (cm) (median (range)) | 3 (0–6) | 3 (1–5) | 0.44 |
| 24 hour pH monitoring | |||
| Total time pH <4 (%) (median (range)) | 0.6 (0–29.9) | 0.6 (0–23.9) | 0.90 |
| Supine time pH <4 (%) (median (range)) | 0 (0–39.6) | 0.05 (0–47.2) | 0.51 |
| Upright time pH <4 (%) (median (range)) | 0.95 (0–47.9) | 0.65 (0–15.8) | 0.57 |
| Maintenance PPI dose (mg) (median (range)) | 20 (20–60) | 40 (20–80) | 0.27 |
| No of endoscopic treatments (median (range)) | 4 (2–6) | 3 (2–6) | 0.76 |
| No of patients with BO reversal (%) | 12 (75.0) | 12 (63.1) | 0.49 |
| (endoscopic and histological ablation) | |||